Stocks and Investing Stocks and Investing
Wed, August 2, 2023

Matt Miksic Maintained (ZBH) at Sell with Increased Target to $120 on, Aug 2nd, 2023


Published on 2024-10-28 05:24:40 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Barclays, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Sell with Increased Target from $116 to $120 on, Aug 2nd, 2023.

Matt has made no other calls on ZBH in the last 4 months.



There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 3 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Travis Steed of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $160 on, Wednesday, May 3rd, 2023
  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $146 on, Wednesday, May 3rd, 2023
  • Lee Hambright of "Bernstein" Maintained at Hold with Increased Target to $152 on, Wednesday, May 3rd, 2023


These are the ratings of the 5 analyists that currently disagree with Matt


  • Jeff Johnson of "Baird" Reiterated at Buy and Held Target at $172 on, Wednesday, June 28th, 2023
  • Rick Wise of "Stifel" Maintained at Strong Buy and Held Target at $165 on, Friday, June 2nd, 2023
  • Shagun Singh of "RBC Capital" Maintained at Buy with Increased Target to $156 on, Wednesday, May 3rd, 2023
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $160 on, Wednesday, May 3rd, 2023
  • Vijay Kumar of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $148 on, Tuesday, April 11th, 2023

Contributing Sources